 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 08/19/2019 |
$65.04 |
$66.88 |
$64.97 |
$66.56 |
9.83M | | 08/20/2019 |
$67.38 |
$68.46 |
$66.33 |
$66.41 |
12.04M | | 08/21/2019 |
$67.34 |
$67.92 |
$66.60 |
$67.54 |
7.62M | | 08/22/2019 |
$67.87 |
$68.03 |
$66.81 |
$67.52 |
6.50M | | 08/23/2019 |
$67.28 |
$67.79 |
$65.48 |
$65.97 |
8.90M |
|
|
| AbbVie is a research-based biopharmaceutical company. Co.'s products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; as well as other serious health conditions. Co. has medicines in clinical development across immunology, oncology and neuroscience, with additional targeted investment in cystic fibrosis and women's health. | |
|
AbbVie (ABBV) has the following price history information. Looking back at ABBV historical stock prices for the last five trading days, on August 19, 2019, ABBV opened at $65.04, traded as high as $66.88 and as low as $64.97, and closed at $66.56. Trading volume was a total of 9.83M shares. On August 20, 2019, ABBV opened at $67.38, traded as high as $68.46 and as low as $66.33, and closed at $66.41. Trading volume was a total of 12.04M shares. On August 21, 2019, ABBV opened at $67.34, traded as high as $67.92 and as low as $66.60, and closed at $67.54. Trading volume was a total of 7.62M shares. On August 22, 2019, ABBV opened at $67.87, traded as high as $68.03 and as low as $66.81, and closed at $67.52. Trading volume was a total of 6.50M shares. On August 23, 2019, ABBV opened at $67.28, traded as high as $67.79 and as low as $65.48, and closed at $65.97. Trading volume was a total of 8.90M shares.
ABBV Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
08/23/2019 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$65.97 |
|
| Starting shares: |
284.74 |
|
| Ending shares: |
368.35 |
|
| Dividends reinvested/share: |
$16.92 |
|
| Total return: |
143.00% |
|
| Average Annual Total Return: |
14.31% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$24,298.74 |
|
| Years: |
6.64 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
08/23/2019 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$65.97 |
|
| Dividends collected/share: |
$16.92 |
|
| Total return: |
136.02% |
|
| Average Annual Total Return: |
13.81% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$23,601.83 |
|
| Years: |
6.64 |
|
|
|
| Date |
Close |
| 08/19/2019 | $66.56 | | 08/20/2019 | $66.41 | | 08/21/2019 | $67.54 | | 08/22/2019 | $67.52 | | 08/23/2019 | $65.97 |
|
|
